[
    "{\"step_by_step_thinking\": \"Sacituzumab govitecan is a drug that has been approved by the FDA for the treatment of metastatic triple-negative breast cancer. This approval was based on clinical trials that showed the drug's effectiveness in treating this type of cancer. Therefore, it can be concluded that sacituzumab govitecan is effective for breast cancer.\", \"answer_choice\": \"A\"}"
]